Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Post by
Pronorvista
on Nov 06, 2023 12:06pm
ATE
Serious buyers arrive in the afternoon.
(31)
•••
Quailman
X
View Profile
View Bullboard History
Comment by
Quailman
on Nov 06, 2023 11:42am
RE:RE:ATE
Nice post, thanks. Not alot for sale. Would not take much to get back over $1.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Comment by
Pronorvista
on Nov 06, 2023 10:56am
RE:ATE
Market By Price Price Total Volume Value 0.980 9,000 $8,820 0.970 500 $485 0.940 500
...more
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Post by
Pronorvista
on Nov 06, 2023 10:55am
ATE
Last chance before the big departure. Market By Order Price Volume House Time 0.860 2,000 TD Sec 09:40 0
...more
(55)
•••
Yellowknifer69
X
View Profile
View Bullboard History
Comment by
Yellowknifer69
on Nov 04, 2023 1:39pm
RE:Looking forward ...
Hello and good afternoon ATE Longs: It is nice to finally see some upward movement of share price. 2023 is almost done but maybe there is one more nice surprise to finish the year out?
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Nov 04, 2023 11:33am
Looking forward ...
Looking forward to this week's update. Is it only about acute? Might we learn something about chronic and/or the new molecule? One release or multiple releases to come? 2023 is a very important
...more
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Post by
Pronorvista
on Nov 03, 2023 3:50pm
ATE
same thing today, pick up the weak hands in the morning, then believe them to buy.
(55)
•••
Harper75
X
View Profile
View Bullboard History
Comment by
Harper75
on Nov 03, 2023 11:56am
RE:Still a long way
I agree we are still have lots of runway ahead before reclaiming previous highs but the historical difference is this phase 2 is significantly derisked compared to our first go-round.
(1202)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 03, 2023 11:31am
Still a long way
away before we get a serious move in the stock, with the original formula ATE did not do much untill they anounced the official start of P2 on march/19/2019. in the month of march the stock price
...more
(1202)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 03, 2023 8:52am
Jobs #'s
less than expected both sides of the border, bad news is good news for the market. not sure it can move up much higher when reality sets in.
(55)
•••
Harper75
X
View Profile
View Bullboard History
Comment by
Harper75
on Nov 03, 2023 8:09am
RE:Could see selling
I'm curious to see the level volatility. Do we have a balance of long term holders with shorter term Penny flippers or does one outweigh the other?
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Post by
Pronorvista
on Nov 02, 2023 4:05pm
ATE
Little volume on the side US . Q:ATBPF - ANTIBE THERAPEUTICS INC - Website unknown - click to update 16:02:33 EDT
...more
(1202)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 02, 2023 3:00pm
Also
us jobs #'s out tomorrow, disapointing results could spook the market
(1202)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 02, 2023 2:48pm
Could see selling
going into the close, likely a red day tomorrow after the strongest day in the market in over a year. also ate has had a good run and may see some selling preasure tomorrow. glta
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Post by
Pronorvista
on Nov 02, 2023 12:47pm
ATE
The serious buyers are starting to come in , the morning picks up the no believers .
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >